Aldeyra Therapeutics (ALDX) EPS (Diluted) (2013 - 2026)
Aldeyra Therapeutics (ALDX) EPS (Diluted) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | 0.00 |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 0.15 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 4.02 |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 6.75 |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | 0.00 |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 7.33 |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 1.49 |
| 10 | Aldeyra Therapeutics | 94.70 Mn | 94.70 Mn | - | -0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.06 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.23 |
| Jun 30, 2025 | -0.17 |
| Mar 31, 2025 | -0.29 |
| Dec 31, 2024 | -0.26 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.28 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.09 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -0.44 |
| Mar 31, 2023 | -0.71 |
| Dec 31, 2022 | -0.23 |
| Sep 30, 2022 | -0.33 |
| Jun 30, 2022 | -0.33 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.30 |
| Sep 30, 2021 | -0.47 |
| Jun 30, 2021 | -0.66 |